Diabetes and Cardiovascular Event Study (5 Years)

This is a study to determine the safety and effectiveness of an investigational medication on lowering the risk of cardiovascular events in people with type 2 diabetes and hypertriglyceridemia.  There is no cost to participate, and participants will be compensated $50.00 per scheduled study visit attended. 

People that meet the following conditions may qualify to receive study medication at no cost:

  • Hypertriglyceridemia (high levels of triglycerides in the blood).
  • A documented history of type 2 diabetes for at least 12 weeks.
  • Men aged 50 and older and women aged 55 and older, or people aged 18 and older with established systemic atherosclerosis (e.g., heart attack, stroke, carotid disease, bypass surgery, etc.).

Participants will be asked to visit the study centre about 22 times with about 16 telephone calls over a period of about 60 months.  There will be no compensation for telephone calls.

Call the study centre near you, or register now.

Learn more about
Diabetes Mellitus Type 2
Learn more about
Register Now!

Participating Locations


  • Sorry no locations are available in this country.


  • Sorry no locations are available in this country.


  • Sorry no locations are available in this country.


  • Sorry no locations are available in this country.

Register for
Active Studies!


All information about you will be kept confidential.

If there are no active studies for your condition, we will keep your information and contact you when a new study starts in your area.

By registering you are consenting to the terms and conditions of our privacy policy.

Find the clinic near you:

Why Take Part In a Clinical Study?

Regulatory agencies like Health Canada, Australia's Therapeutic Goods Administration and the FDA require that Clinical Research Trials be conducted in order to develop new treatments, preventions and devices for diseases or conditions. Clinical Research Trials are also referred to as Clinical Studies or Clinical Trials. read more